[{"Assets_0_Q2_USD":3200000.0,"CommonStockSharesOutstanding_0_Q2_shares":94599601.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-11549000.0,"NetIncomeLoss_1_Q2_USD":-3236000.0,"NetIncomeLoss_2_Q2_USD":-12651000.0,"StockholdersEquity_0_Q2_USD":-8731000.0,"Ticker":"OCGN","CIK":"1372299","name":"HISTOGENICS CORP","OfficialName":"Ocugen Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"583661968.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190809"}]